Get the Stockscreener App
41.69
0.14%
0.105
Renaissance Ipo Etf stock is traded at $41.69, with a volume of 16,515.
It is up +0.14% in the last 24 hours and down -7.12% over the past month.
See More
Previous Close:
$41.58
Open:
$41.29
24h Volume:
16,515
Relative Volume:
0.50
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-5.56%
1M Performance:
-7.12%
6M Performance:
+1.04%
1Y Performance:
+6.61%
1-Day Range:
$41.17
$42.12
1-Week Range:
$41.17
$44.14
52-Week Range:
$34.06
$48.23
Renaissance Ipo Etf Stock (IPO) Company Profile
Name
Renaissance Ipo Etf
Sector
Industry
Phone
-
Address
-
Compare IPO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IPO
Renaissance Ipo Etf
|
41.47 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
288.99 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
585.67 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
588.55 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
235.38 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
501.08 | 124.43B | 0 | 0 | 0 | 0.00 |
Renaissance Ipo Etf Stock (IPO) Latest News
(IPOS) Trading Report - Stock Traders Daily
When (IPO) Moves Investors should Listen - Stock Traders Daily
Basel Medical Group stock edges up 4% following U.S. IPO - MSN
IPO Roundup: Advanced Biomed, Brag House Holdings and more (IPO:NYSEARCA) - Seeking Alpha
IPO NewsUS IPO Weekly Winners & Losers - Renaissance Capital
IPO Roundup: Anbio Biotechnology, Wellgistics Health and more (IPO:NYSEARCA) - Seeking Alpha
Renaissance International IPO ETF (NYSEARCA:IPOS) Stock Price Up 1.7% – Still a Buy? - Defense World
Objective long/short (IPO) Report - Stock Traders Daily
A Bullish 2025 for the IPO Market? ETFs to Consider - MSN
Kestra Medical, wearable device maker, files for $100M IPO - MSN
IPO Roundup: Karman Space & Defense, Aardvark Therapeutics and more (NYSEARCA:IPO) - Seeking Alpha
US IPO Weekly Winners & Losers - Renaissance Capital
IPO Roundup: Titan America, Aureus Greenway and more (IPO:NYSEARCA) - Seeking Alpha
Maze Therapeutics stock hugs flat line following $140M IPO - MSN
Cloudastructure: CSAI IPO, TechnologyOffers AI-enabled video surveillance. - Renaissance Capital
10 Funds Hit Hardest by the DeepSeek AI Stock Downturn - Morningstar
Obesity drug developer Aardvark files for IPO - MSN
IPO Roundup: Smithfield Foods, Beta Bionics and more (NYSEARCA:IPO) - Seeking Alpha
Where are the Opportunities in (IPOS) - Stock Traders Daily
IPO Rebound In 2025? Here's What's Fueling The Boom, How ETFs Can Help Investors Capitalize - Benzinga
Obesity drug developer Aardvark files for IPO (IPO:NYSEARCA) - Seeking Alpha
A Bullish 2025 For The IPO Market? ETFs To Consider - Barchart
IPO Roundup: Toppoint, Venture Global and more (NYSEARCA:IPO) - Seeking Alpha
SailPoint Parent files for $100M IPO - MSN
Renaissance Ipo Etf Stock (IPO) Financials Data
There is no financial data for Renaissance Ipo Etf (IPO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.08%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):